Global Digital Health Market Forecast to 2026
Digital health is a cluster of multiplatform technologies that involves use of new age information communication technologies that utilizes digital, mobile and cloud based platforms in order to provide quality healthcare to patients. Digital health platforms such as tele medicine, tele care let health beneficiary to connect with health care provider. Digital Health synergies right information at the right place at the right time for use by the right healthcare provider. Digital health also involves utilization of the mobile health (mHealth), health information technology (IT), wearable devices, tele health and telemedicine, and personalized medicine. Digital health platform brings the stakeholder in healthcare system such as patients, health care practitioners, researchers, medical device industry firms, and as mobile application developers (mHealth provider) more closely and makes whole healthcare system efficient.
Digital health is a cluster of multiplatform technologies that involves use of new age information communication technologies that utilizes digital, mobile and cloud based platforms in order to provide quality healthcare to patients. Digital health platforms such as tele medicine, tele care let health beneficiary to connect with health care provider. Digital Health synergies right information at the right place at the right time for use by the right healthcare provider. Digital health also involves utilization of the mobile health (mHealth), health information technology (IT), wearable devices, tele health and telemedicine, and personalized medicine. Digital health platform brings the stakeholder in healthcare system such as patients, health care practitioners, researchers, medical device industry firms, and as mobile application developers (mHealth provider) more closely and makes whole healthcare system efficient.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
hydrogels as novel excipient and carrier. Moreover, high prevalence of chronic disease such as<br />
cancer is propelling growth of the market. For instance, according <strong>to</strong> the data published by<br />
International Journal of Pharma Sciences and Research (IJPSR), around 9 million deaths occurred<br />
due <strong>to</strong> cancer in 2015, and around 11.4 million people are estimated <strong>to</strong> die due <strong>to</strong> cancer by<br />
2030. Such high number of deaths is propelling demand for development of novel molecule with<br />
effective targeting of drug <strong>to</strong>wards diseased organ, which can be achieved with hydrogel due <strong>to</strong><br />
its extracellular characteristics, which would also decrease side effects associated <strong>to</strong> anti-cancer<br />
drugs.<br />
Hydrogel act as an effective carrier in skin cancer. Hydrogel such as hyaluronic acid is used as<br />
tissue filler for plastic reconstruction surgery such as breast reconstruction. This surgery is<br />
conducted if breast cancer treatment compels <strong>to</strong> remove affected tissue mass. Increasing<br />
adoption of immunotherapy <strong>to</strong> treat various disease such as asthma and Crohn’s disease are<br />
expected <strong>to</strong> fuel growth of the medical grade hydrogel market. A nanovec<strong>to</strong>r composed of<br />
peptide-based nanofibrous hydrogel can condense DNA <strong>to</strong> result in strong immune responses<br />
against disease such as HIV. HIV is one of the major cause of deaths globally. According <strong>to</strong><br />
UNAIDS factsheet, in 2016, around 36.7 million were suffering from HIV worldwide. Hydrogels are<br />
majorly used in proteomics and electrophoresis as replacement <strong>to</strong> other types of polymers.<br />
Smart hydrogels and tissue engineering are future research areas for hydrogel, which would aid<br />
in medical application and drive growth for medical grade hydrogel market.<br />
According <strong>to</strong> report published by American Society of Plastic Surgeons 2017, around 290,467<br />
breast augmentation surgeries were performed in 2016, which increased <strong>to</strong> 300,378 in 2017.<br />
High prevalence of the chronic disease such as cancer and cardiovascular disease and extensive<br />
research and development by pharmaceutical and biotech companies for development of<br />
innovative products are driving market growth. According <strong>to</strong> the estimation of Pharmaceutical<br />
Research and Manufacturers of America (PhRMA), in 2017, pharmaceutical industry invested<br />
around US$ 0.8 billion <strong>to</strong> US$ 1.7 billion per company on research and development activities.<br />
Europe is projected <strong>to</strong> witness significant growth in the medical grade hydrogel market.<br />
Browse More About the Keyword <strong>Market</strong> Study @<br />
https://www.coherentmarketinsights.com/ongoing-insight/medical-grade-hydrogel-market-<br />
1906<br />
Report includes chapters which deeply display the following deliverable about industry:<br />
• Medical Grade Hydrogel <strong>Market</strong> Research Objective and Assumption<br />
• Medical Grade Hydrogel <strong>Market</strong> Purview - Report Description, Executive Summary, and Coherent<br />
Opportunity Map (COM)<br />
• Medical Grade Hydrogel <strong>Market</strong> Dynamics, Regulations, and Trends Analysis - <strong>Market</strong> Dynamics,<br />
Regula<strong>to</strong>ry Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value<br />
Chain Analysis, Porter’s Analysis, and PEST Analysis<br />
• <strong>Global</strong> Medical Grade Hydrogel <strong>Market</strong>, By Regions<br />
• Medical Grade Hydrogel <strong>Market</strong> Competition by Manufacturers including Production, Share,
Change language